SCHEMBL15052052

SCHEMBL15052052

COc1ccc(C=CC(=O)O)c(OC(C)=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.61
ALDH1A1 P00352 3/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
NPC1 O15118 3/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TNFRSF1A P19438 1/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
LY96 Q9Y6Y9 1/20 0.53
MAPK1 P28482 1/20 0.52
CYP1A1 P04798 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 1/20 0.52
CYP1B1 Q16678 2/20 0.51
THRB P10828 1/20 0.51
ATM Q13315 1/20 0.51
F2 P00734 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9469778 0.88 CYP1A1 (0.62) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL9469775 0.88 CYP1A1 (0.62) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL79456 0.88 MAPT (0.79) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27892982 0.88 MAPT (0.79) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL79457 0.88 MAPT (0.79) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL29449851 0.88 MAPT (0.79) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27858760 0.86 MAPT (0.77) MAPTALDH1A1MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL15299858 0.86 MAPT (0.77) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL13075036 0.84 MAPT (0.63) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL9055047 0.83 ALDH1A1 (0.71) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853276-B2 Guanidine derivatives in cinnamic series PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) 2014-10-07 US disclosed
US-20130165507-A1 NEW GUANIDINE DERIVATIVES IN CINNAMIC SERIES PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165507-A1 NEW GUANIDINE DERIVATIVES IN CINNAMIC SERIES GMPS, UNG, AGER MAPT 2457/4885ALDH1A1 204/4885MEN1 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.